The weekly litigation news digest is live. Subscribe now

Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters - EP2234617

The patent EP2234617 was granted to Janssen Pharmaceutica on Nov 6, 2024. The application was filed on Dec 17, 2008 under application number EP08863534A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2234617

JANSSEN PHARMACEUTICA
Application Number
EP08863534A
Filing Date
Dec 17, 2008
Status
Patent Maintained As Amended
Oct 3, 2024
Publication Date
Nov 6, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (20)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2003064998
INTERNATIONAL-SEARCH-REPORTUS2007197591
OPPOSITIONEP0904081
OPPOSITIONEP1033987
OPPOSITIONUS2006079846
OPPOSITIONUS20070014918P
OPPOSITIONUS2007197591
OPPOSITIONUS20080120276P
OPPOSITIONUS5254556
OPPOSITIONUS6077843
OPPOSITIONUS6555544
OPPOSITIONWO2004018312
OPPOSITIONWO2006114384
OPPOSITIONWO2009080651
OPPOSITIONWO9744039
OPPOSITIONWO9925354
OTHERUS6555544

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents